In addition to HLA-A-restricted T-cell response, HLA-B and HLA-C allele-restricted T-cell responses against NPM-ALK have also been recently identified in 40% of pediatric or adolescent NPM-ALK ALCL patients [35]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.